Episode 68: The Future of Precision Medicine, AI, and Biotech with Key Opinion Leader Veronique Bouchet
What if AI could help you get the right treatment at the right time for your unique health needs?
In this episode, host James Zanewicz, JD, LLM, RTTP, sits down with Veronique Bouchet, MBA, Chief Medical Officer at PrecisionLife, to discuss how AI is driving innovation in precision medicine. Together, they explore the challenges of tackling complex and chronic diseases, PrecisionLife’s unique AI-driven approach, and how these advancements are improving patient outcomes and reducing healthcare costs.
In this episode, you’ll discover:
- How PrecisionLife’s platform addresses major challenges in complex and chronic disease management.
- The key differences between traditional drug development methods and AI-enabled strategies.
- Insights into the evolving role of a Chief Medical Officer in a tech-bio company.
Tune in to learn how PrecisionLife is reshaping healthcare and making a real impact on patients’ lives!
Links:
Connect with Veronique Bouchet, MBA, and learn more about PrecisionLife.
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the Milken Institute, The Bullpen, and Chris Yochim.
Learn about PrecisionLife’s work on ME/CFS Risk Factors and their partnership with Metrodora Institute.
Check out the events PrecisionLife will be attending.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
